GO
Loading...
 
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Merck suffering through generic competition: Expert

Mon 28 Oct 13 | 07:47 AM ET
Barbara Ryan, FTI Consulting managing director, breaks down the pharmaceutical company's earnings and weighs in on two promising drugs in the pipeline, as the company ramps up research and development.
 
RELATED ARTICLES AND CONTENT
More Videos
Latest Videos
Banking on new digital media
Mon 21 Apr 14 | 08:37 AM ET
Latest Videos
Boston mayor on marathon security
Mon 21 Apr 14 | 08:33 AM ET
Latest Videos
What to expect from Yellen
Mon 21 Apr 14 | 08:31 AM ET
Latest Videos
Labor market stronger than Fed thinks: Expert
Mon 21 Apr 14 | 08:16 AM ET
Go
Displaying results for: Latest Video | US